Chemotherapy-related - and late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors?

Leukemia

Volumn 11, Issue 9, 1997, Pages 1571-1574

  Pedersen Bjergaard, J ^a   Brondum Nielsen K ^b   Karle, H ^c   Johansson, B ^d  

^a University of Copenhagen   (Denmark)

^b JOHN F KENNEDY INSTITUTE   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

DNA topoisomerase II inhibitors; Philadelphia chromosome; Secondary leukemia; Therapy related leukemia

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; GYRASE INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; GERM CELL TUMOR; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MALE; MEDICAL LITERATURE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0030763394     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400769     Document Type: Article

References (24)

1. Pedersen-Bjergaard J, Rowley JD. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994; 83: 2780-2786.
2. Pedersen-Bjergaard J, Philip P. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II. Blood 1991; 78: 1147-1148.
3. Larson RA, Le Beau MM, Ratain MJ, Rowley JD. Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia. Blood 1992; 79: 1892-1893.
4. 1-positive acute leukemia in a patient with Hodgkin's disease treated by irradiation and chemotherapy. Neoplasma 1986; 33: 355-359.
5. Dallorso S, Sessarego M, Garré ML, Haupt R, Pasino M, Sansone R. Secondary acute promyelocytic leukemia with t(8;21) and t(9;22) at onset and loss of the Philadelphia chromosome at relapse. Cancer Genet Cytogenet 1990; 47: 41-46.
6. Verhoef GEG, Demuynck H, Stul MS, Cassiman JJ, Mecucci C, Van den Berghe H, Boogaerts MA. Philadelphia chromosomepositive chronic myelogenous leukemia in treated Hodgkin's disease. Cancer Genet Cytogenet 1990; 49: 171-176.
7. Bouabdallah K, Marit G, Reiffers J, Braustet A, Bilhou-Nabera C, Wen ZQ, Bernard P. Hodgkin's disease and secondary Philadelphia chromosome positive chronic myelogenous leukemia. Cancer Genet Cytogenet 1991; 55: 277-278.
8. Berman E, Strife A, Wisniewski D, Desai S, Gulati S, Jhanwar S, Clarkson BD. Duration of the preclinical phase of chronic myelogenous leukemia: a case report. Blood 1991; 78: 2969-2972.
9. Jackson GH, Latham JA, Lennard AL, Taylor PRA, Proctor SJ. Rapid onset of chronic granulocytic leukaemia after treatment for Hodgkin's disease. Br J Haematol 1994; 87: 193-195.
10. Auerbach HE, Stelmach T, LaGuette JG, Glick JH, Kant JA, Nowell PC. Secondary Ph-positive CML with a minority monosmy 7 clone. Cancer Genet Cytogenet 1987; 28: 173-178.
11. Alimena G, Cedrone M, Nanni M, De Cuia MR, Lo Coco F, De Sanctis V, Cimino G, Mancini M. Acute leukemia presenting a variant Ph chromosome svith p190 expression, dup 3q and -7, developed after malignant lymphoma treated with alkylating agent agents and topoisomerase II inhibitors. Leukemia 1995; 9: 1483-1486.
12. Aguiar RCT, Sill H, Hochhaus A, Goldman JM, Cross NCR. Molecular investigation of secondary chronic myeloid leukemia. Blood 1996; 88: 2808-2809.
13. Nakamura K, Inaba T, Nishimura J, Morgan GJ, Hayashi Y, Hanada R, Yamamoto K, Wada H, Kawaguchi H, Miyashita T, Wiedemann LM, Mizutani S. Molecular analysis of BCR/ABL products in a case of myelodysplastic syndrome with late appearing Philadelphia chromosome. Br J Haematol 1991; 78: 130-132.
14. Jacobsen RJ, Himoe E, Sacher RA, Shashaty GG. Late appearance of Philadelphia chromosome. Br J Haematol 1986; 63: 392-394.
15. BCR-ABL in two patients with late appearing Philadelphia chromosome-positive acute nonlymphocytic leukemia. Leukemia 1989; 3: 841-846.
16. Shimamoto T, Ohyashiki K, Ohyashiki JH, Fujimura T, Kodama A, Miyazawa K, Aizawa S, Toyama K. Late appearance of a Philadelphia translocation with minor-BCR/ABL transcript in a t(7;11)(p15;p15) acute myeloid leukemia. Leukemia 1995; 9: 640-642.
17. Van den Berghe E, Martiat P, Baens M, Stul M, Ferrant A, Cuneo A, Cassiman JJ, Mecucci C, Van den Berghe H. Megakaryoblastic leukemia with an N-ras mutation and late acquisition of a Philadelphia chromosome. Leukemia 1991; 5: 683-686.
18. Miller BA, Reid MM, Nell M, Lipton JM, Sallan SE, Nathan DC, Tantravahi R. T-cell acute lymphoblastic leukaemia with late developing Philadelphia chromosome. Br J Haematol 1984; 56: 139-146.
19. Sessarego M, Defferrari R, Dejana A, Salvidio E. Late-appearing Philadelphia chromosome in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1990; 48: 35-38.
20. Coad JE, Arthur DC, Gajl-Peczalska KJ, Litz CE. Late-developing Philadelphia chromosomes in case of T-cell acute lymphoblastic leukemia. Leukemia 1994; 8: 889-894.
21. Tsuchiya H, Migita M, Yamamori S, Kaneko Y, Adachi N, Nakamura T, Nobukuni Y, El-Sonbaty SS, Matsuda I. A late-appearing Philadelphia chromosome in acute lymphoblastic leukemia confirmed by expression of BCK-ABL mRNA. Leukemia 1995; 9: 1689-1693.
22. 1) chromosome in acute lymphocytic leukemia. Blood 1996; 88 (Suppl. 1): Abstr. 3332.
23. Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard C, Ersboll J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC, Specht L, Østerlind K. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 1993; 7: 1975-1986.
24. Pedersen-Bjergaard J. Editorial. Acute lymphoid leukemia with t(4;11) (q21;q23) following chemotherapy with cytostatic agents targeting at DNA-topoisomerase II. Leukemia Res 1992; 16: 733-735.